SHL Siemens Healthineers AG

48.06USD43.82 EUR · XETRA-0.05%Mkt Cap: 53.79B USDP/E: 22.24

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS,…

Institutional holders12 on file

Key Statistics

Company
Market Cap53.79B USD
Enterprise Value66.83B USD
Revenue (TTM)25.92B USD
Gross Profit10.00B USD
Net Income (TTM)2.43B USD
Revenue/Share23.18 USD
Last Price48.06 USD
Fiscal Year EndSep 2026
MR QuarterSep 2026
Employees74.6K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINDE000SHL1006
Valuation
P/E (Trailing)22.24
P/E (Forward)16.65
PEG2.13
EV/EBITDA13.91
EV/Revenue2.58
P/S2.08
P/B2.45
EPS (TTM)2.16 USD
EPS (Forward)2.89 USD
52W Range
35.9965% of range54.52
52W High54.52 USD
52W Low35.99 USD
Profitability
Gross Margin38.57%
Oper. Margin13.52%
EBITDA Margin18.54%
Profit Margin9.37%
ROE11.15%
ROA4.74%
ROIC13.91%
ROCE9.54%
Growth
Revenue Growth7.30%
Earnings Growth-0.80%
Cash Flow & Leverage
Operating CF3.61B USD
CapEx (TTM)923.51M USD
FCF Margin7.28%
FCF Yield3.51%
Net Debt13.38B USD
Net Debt/EBITDA2.78
Net Debt/FCF7.10
Balance Sheet
Debt/Equity0.04
Current Ratio1.18
Quick Ratio0.75
Book Value/Sh19.60 USD
Cash/Share2.51 USD
Dividends
Fwd Div Rate1.10 USD
Trail. Div Rate1.10 USD
Div. Yield2.31%
5Y Avg Yield1.89%
Payout Ratio50.76%
Ex-Div DateFeb 6, 2026
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)51.27 USD
Upside (mean)+6.7%
Target Range40.58 USD – 62.96 USD
40.58+6.7% to mean62.96
# Analysts20
Ownership
Shares Out.1.12B
Float355.68M
Insiders67.02%
Institutions14.18%
Technical
SMA 5044.55 (+7.9%)
SMA 20041.53 (+15.7%)
Beta0.89
S&P 52W Chg12.00%
Avg Vol (30d)1.00M
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)60.8
MACD0.8495
MACD Signal1.0128
MACD Hist.-0.1633
BB Upper49.54 USD
BB Middle47.60 USD
BB Lower45.66 USD
BB Width8.15%
ATR (14)1.020 USD
Vol Ratio (20d)0.88x

About Siemens Healthineers (ETR: SHL)

›

Siemens Healthineers (ETR: SHL) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 74,600 employees.

The shares were at 43.82 EUR on 19 November 2026, down 4.8% over 52 weeks. Its 52-week range is 32.81 EUR to 49.71 EUR: the price is 11.8% below the high and 33.6% above the low.

At a market capitalisation of 49.04B EUR, it trades at 22.2 times trailing earnings and 16.7 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 13% for SHL. It pays a dividend yielding 2.31% (it pays out 51% of its earnings), against a median of 2.41% among the dividend payers in that peer group.

Siemens Healthineers reports return on equity of 11.2%, an operating margin of 13.5% and revenue up 7.3% year over year.

Its debt exceeds its cash by 12.20B EUR, a debt-to-equity ratio of 0.04. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 46.74 EUR is 6.7% above the current price. The next earnings report is expected on 4 February 2027.